Web figure 2: Article retrieval and screening process for main review (all carbohydrates and cardio-metabolic diseases) and update review (dietary fibre and CVD/CHD risk)
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Web Figure 3 : Newcastle-Ottawa Quality Assessment Scale for Cohort Studies 1 : Details of how the criteria were applied for cohort studies assessing the relationship between dietary fibre intake and CVD Selection 1) Representativeness of the exposed cohort  Star assigned if cohort was truly or somewhat representative of the average fibre-consumer in the community (i.e. the sample was random or covered all persons living in one or a few geographical areas). Note that stars were assigned even where an age restriction may have been applied to the recruitment sample. 2) Selection of non-exposed cohort  Star assigned where non-exposed persons were drawn from the same population as the exposed participants. 3) Ascertainment of exposure  Star assigned where diet had been assessed using structured interview. 4) Demonstration that outcome of interest was not present at the start of study  Star assigned where the article stated that participants with prevalent CVD were excluded from analysis. Note that stars were not assigned to studies with mortality as an outcome unless participants with history of CVD had been excluded. Comparability 1) Comparability of cohorts on the basis of the design or analysis  One star assigned where age was controlled for in analysis.  Second star assigned where other important potential confounders were controlled for in analysis. Outcome 1) Assessment of outcome  Star assigned where outcomes were identified through medical records/ record linkage. 2) Was follow-up long enough for outcomes to occur  Star assigned where follow-up was a minimum of 3 years, as per the review protocol. 3) Adequacy of follow up of cohorts  Star assigned where the loss to follow-up had been estimated for the study and reported in the article and where loss was less than 30%.
Web figure 4: Insoluble fibre intake and risk of CHD and CVD Note that scores may differ between publications from the same cohort study as scores were assigned on the information provided within each separate report.
Web P het * Heterogeneity within each subgroup; P het † Heterogeneity between each subgroup. Abbreviations: AOAC Association of Official Analytical Chemists; CI confidence intervals; EU European Union; n Number of studies; RR relative risk. Note, where numbers do not sum to the total number of studies in the analysis, this is because this information was not available from a study.
